Prevention Genetics LogoExact Sciences is now Abbott
Test Code 10213
New York approved

Spondylocostal Dysostosis Panel

6 genes

2 - 3 weeks (6 - 12 days STAT)

Who is this test for?
  • Individuals with relevant features who have a clinical or suspected diagnosis of Spondylocostal Dysostosis
  • Individuals with vertebral segmentation defects identified on fetal ultrasound as early as 13 weeks gestation
  • Individuals from Puerto Rican families with suspected MESP2-related Spondylocostal Dysostosis
Method
NGS with CNV (Exome or Genome Platform)
Specimen(s)

Exome Platform: Blood, DNA, Buccal, Saliva, Tissue

Genome Platform: Blood, DNA

Order Options

OTHER OPTIONS
for standard institutional pricing.

Explore related tests

Questions? We can help.

Getting support has never been easier. Let us connect you with our specialists that will assist you with anything from understanding products to navigating insurance questions.